Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00784823 · MORE INFO

Limitations, agreements, and source contact

Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma · Source last updated 2022-08-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
The limited number of patients limited our ability to analyze groups separately for adverse event reporting. As a result, adverse events were collected irrespective of dose and therefore cannot be separated further.
point Of Contact
email
Joshua.Zenreich@hmhn.org
organization
Hackensack Meridian Health
phone
551-996-4248
title
Joshua Zenreich
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
The limited number of patients limited our ability to analyze groups separately for adverse event reporting. As a result, adverse events were collected irrespective of dose and therefore cannot be separated further.
point Of Contact
email
Joshua.Zenreich@hmhn.org
organization
Hackensack Meridian Health
phone
551-996-4248
title
Joshua Zenreich

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice